Hari Om Pipes Share Price: What Investors Should Know in 2025 {update}

Since its IPO, the stock has shown significant growth due to its consistent performance and strong industry demand. The company is listed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).

Hariom Pipe Share Price – July 2025 Overview

The stock has recently rebounded after hitting a low near ₹466 and is now approaching the ₹500 resistance level again. The 52-week range for the stock is between ₹301 and ₹888.

Financial Highlights (FY25 and Q1 FY26)

• Market Cap: ₹1,543–₹1,552 crore
• P/E Ratio: Around 23 to 25 times earnings
• P/B Ratio: 2.5 times book value
• ROCE: 14.1%
• ROE: 11.9%
• Dividend: Final dividend of ₹0.61 per share announced in May 2025

Q4 FY25 Results (Announced in May 2025)

• Revenue: ₹399.7 crore (Up 20.8% YoY)
• Operating Profit: ₹35.24 crore (Up 8.8% YoY)
• Net Profit: ₹17.24 crore (Up 2.8% YoY)

Q1 FY26 Update

• Sales volume increased by 35% year-on-year
• 96% of the sales came from value-added products

These results reflect the company’s strong focus on efficiency, quality, and its ability to meet growing demand across sectors.

Also Read: Shakti Pumps Share Price Target 2025 to 2040 Fundamental Analysis

Latest Updates and News

1. July 17, 2025 – Temporary shutdown for maintenance at the Mahabubnagar plant
2. May 9, 2025 – Board meeting approved final audited financials and dividend
3. Next Earnings Date – August 7, 2025

Investors should watch the August earnings closely, as it may influence the next major price move for the stock.

Technical Analysis

• Support zone: ₹460 to ₹465
• Resistance zone: ₹498 to ₹510
• Volatility is moderate with a beta close to 1.03

Trading experts suggest using technical levels to place stop-loss and entry points, especially for short-term positions.

Should You Invest in Hariom Pipe Now?

Reasons to Consider:

• Strong quarterly results and future growth visibility
• Rising demand from infrastructure and housing sectors
• Promoter holding above 55%, with increasing institutional interest
• Focus on value-added products improving margins

Risks to Watch:

• Fluctuation in steel prices may impact margins
• High competition from other pipe manufacturers
• Macroeconomic slowdown or project delays may reduce demand

Investors looking for mid-cap industrial stocks with growth potential may consider adding Hariom Pipe to their portfolio. However, portfolio diversification is recommended to manage sectoral risk.

Where to Track Hariom Pipe Share Price

• NSE India
• BSE India
• Financial platforms like Moneycontrol, TradingView, Zerodha, Upstox

Summary

Hariom Pipe is showing resilience and long-term potential, supported by strong financials and consistent demand in core sectors. Investors should monitor key events such as the upcoming Q1 results in August 2025 and plant operations after the recent shutdown. Technical levels suggest a short-term opportunity, while long-term fundamentals remain stable.

To maximize your research, consider comparing Hariom Pipe with peer stocks and tracking financial performance quarterly.

FAQs

1. What is the current share price of Hari Om Pipes?
   You can check real-time share prices on financial platforms like BSE or NSE.
2. Is Hari Om Pipes a good investment?
   Based on its strong market presence and growth potential, it could be a good investment. However, it’s crucial to do thorough research.
3. What factors impact the share price of Hari Om Pipes?
   Market performance, industry trends, competition, and government policies are the key factors that influence the share price.
4. How can I invest in Hari Om Pipes shares?
   You can buy shares through stock brokers or online trading platforms that support BSE or NSE trading.

The Hari Om Pipes share price in 2024 is poised to experience growth, driven by strong market demand and favorable industry trends. However, as with any investment, it’s essential to stay informed and evaluate risks carefully. Keep an eye on the company’s performance and broader market conditions to make well-timed decisions.